In the fascinating interplay of viral, hormonal, and immunological responses to COVID-19, an intriguing pattern emerges: premenopausal women exhibit a more robust expression of ACE2 and ERα, highlighting their uniqueness compared to postmenopausal women and affected men. This evidence concerns the gene ESR1 and COVID-19.